iRhythm Technologies stock price target raised to $244 from $193 at Needham

Investing.comFriday, October 31, 2025 at 10:41:42 AM
iRhythm Technologies stock price target raised to $244 from $193 at Needham
iRhythm Technologies has received a significant boost as Needham raises its stock price target from $193 to $244. This adjustment reflects growing confidence in the company's performance and potential for future growth, which is great news for investors and stakeholders alike. Such positive revisions can often lead to increased interest in the stock, potentially driving its price higher.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
iRhythm Technologies price target raised to $220 from $205 at Freedom Capital
PositiveFinancial Markets
iRhythm Technologies has received an optimistic boost as Freedom Capital raises its price target from $205 to $220. This adjustment reflects growing confidence in the company's performance and potential for future growth, which is significant for investors looking for promising opportunities in the healthcare technology sector.
Needham upgrades TalkSpace stock to Buy on payor growth outlook
PositiveFinancial Markets
Needham has upgraded TalkSpace's stock to a 'Buy' rating, citing a positive outlook on payor growth. This upgrade is significant as it reflects confidence in TalkSpace's potential to expand its market presence and improve financial performance, which could attract more investors and boost the company's stock value.
Needham reiterates Buy on Roblox stock, maintains $159 price target
PositiveFinancial Markets
Needham has reaffirmed its 'Buy' rating on Roblox stock, setting a price target of $159. This endorsement highlights the firm's confidence in Roblox's growth potential and market position, suggesting that investors may see significant returns as the company continues to innovate and expand its platform.
iRhythm Technologies stock bounces after beating Q3 expectations
PositiveFinancial Markets
iRhythm Technologies saw a significant bounce in its stock price after surpassing Q3 earnings expectations, which is great news for investors. This positive performance not only reflects the company's strong operational capabilities but also boosts investor confidence in its future growth potential. Such results can lead to increased interest from both current and potential shareholders, making it a noteworthy event in the stock market.
Earnings call transcript: iRhythm Technologies beats Q3 2025 forecasts
PositiveFinancial Markets
iRhythm Technologies has exceeded expectations in its Q3 2025 earnings call, showcasing strong financial performance and growth potential. This is significant as it reflects the company's resilience and ability to innovate in the healthcare technology sector, which could lead to increased investor confidence and market interest.
Thryv stock price target lowered to $14 at Needham on SaaS growth concerns
NegativeFinancial Markets
Thryv's stock price target has been lowered to $14 by Needham due to concerns over its SaaS growth. This adjustment reflects the market's cautious outlook on Thryv's ability to expand in the competitive software-as-a-service sector, which is crucial for its long-term success. Investors should pay attention to these developments as they could impact Thryv's market performance and investor confidence.
Needham raises Glaukos stock price target to $117 on strong iDose sales
PositiveFinancial Markets
Needham has raised its price target for Glaukos stock to $117, driven by impressive sales of the iDose product. This increase reflects strong market confidence in Glaukos' innovative solutions for glaucoma treatment, highlighting the company's potential for growth and profitability. Investors are likely to view this as a positive sign for the company's future performance.
TransMedics stock maintains Buy rating at Needham despite revenue miss
NeutralFinancial Markets
TransMedics has retained its Buy rating from Needham, even though the company reported a revenue miss. This is significant as it indicates that analysts still see potential in TransMedics despite the shortfall, suggesting confidence in the company's long-term growth prospects. Investors may find this reassuring as it reflects a belief in the company's future performance.
Latest from Financial Markets
What If You Spent Every Waking Moment Taking On Elon Musk?
NeutralFinancial Markets
Aaron Greenspan, a once-promising entrepreneur, has dedicated the last two decades to challenging some of the most influential figures in the tech industry, including Elon Musk. This relentless pursuit raises questions about the impact of individual voices in a landscape dominated by powerful moguls, highlighting the ongoing struggle between innovation and established authority.
Trump administration cannot suspend food aid benefits, US judges rule
PositiveFinancial Markets
In a significant ruling, US judges have determined that the Trump administration cannot suspend food aid benefits, ensuring continued support for millions of Americans in need. This decision is crucial as it protects vulnerable populations who rely on these benefits for their daily sustenance, highlighting the importance of food security in the country.
Earnings call transcript: BMW Q2 2025 maintains guidance despite China challenges
NeutralFinancial Markets
In its recent earnings call, BMW reported that it is maintaining its guidance for Q2 2025 despite facing challenges in the Chinese market. This is significant as it reflects the company's resilience and strategic planning in navigating potential obstacles. Investors and stakeholders will be keen to see how BMW adapts to these challenges while continuing to meet its financial targets.
Bel Fuse declares quarterly dividends for Class A and B shares
PositiveFinancial Markets
Bel Fuse has announced quarterly dividends for its Class A and B shares, reflecting the company's strong financial performance and commitment to returning value to its shareholders. This move is significant as it not only rewards investors but also signals confidence in the company's future growth prospects.
Earnings call transcript: Yapi ve Kredi Bankasi Q3 2025 shows strong profit growth
PositiveFinancial Markets
Yapi ve Kredi Bankasi has reported impressive profit growth in its Q3 2025 earnings call, showcasing the bank's strong financial performance and resilience in a competitive market. This positive trend is significant as it reflects the bank's effective strategies and operational efficiency, which could inspire confidence among investors and stakeholders.
Tesla hints at flying car prototype unveiling
PositiveFinancial Markets
Tesla has teased the upcoming unveiling of a flying car prototype, sparking excitement in the tech and automotive communities. This development could revolutionize personal transportation, making it faster and more efficient. As Tesla continues to push the boundaries of innovation, this flying car could represent a significant leap forward in how we think about travel, potentially changing the landscape of urban mobility.